Featured article

PKC-mediated RhoGDI interaction with p75NTR JUX domain


Carlos Ibanez starts new laboratories at Peking University and Chinese Institute for Brain Research

Starting in January 2020, new twin laboratories dedicated to studies of growth factor receptor signaling and physiology will be established at the McGovern Institute of the School of Life Sciences in Peking University, and the Chinese Institute for Brain Research in Beijing, China. The research activities of the PKU and CIBR labs will run in parallel to and complement with those ongoing at the KI and NUS laboratories. The initial focus of the new labs will be on studies of death receptor signaling in neurodegeneation, metabolic regulation by activin receptors ALK4 and ALK7, and control of brain microvasculature integrity and function by neurotrophin signaling. PhD students, postdoctoral fellows and lab technicians are being recruited for the new Beijing laboratories. Follow developments in the PKU and CIBR labs at HERE